BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 9882513)

  • 21. EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors.
    Hu-Lieskovan S; Zhang J; Wu L; Shimada H; Schofield DE; Triche TJ
    Cancer Res; 2005 Jun; 65(11):4633-44. PubMed ID: 15930281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of N-linked glycosylation in cell-cycle progression and initiation of DNA synthesis in tumor-transformed human fibroblasts.
    Carlberg M; Larsson O
    Anticancer Res; 1993; 13(1):167-71. PubMed ID: 8476209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts.
    Ouchida M; Ohno T; Fujimura Y; Rao VN; Reddy ES
    Oncogene; 1995 Sep; 11(6):1049-54. PubMed ID: 7566963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EWS/FLI1 regulates tumor angiogenesis in Ewing's sarcoma via suppression of thrombospondins.
    Potikyan G; Savene RO; Gaulden JM; France KA; Zhou Z; Kleinerman ES; Lessnick SL; Denny CT
    Cancer Res; 2007 Jul; 67(14):6675-84. PubMed ID: 17638877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation and forced expression of EWS-Fli1 fusion gene results in changes in the expression of G(1)regulatory genes.
    Matsumoto Y; Tanaka K; Nakatani F; Matsunobu T; Matsuda S; Iwamoto Y
    Br J Cancer; 2001 Mar; 84(6):768-75. PubMed ID: 11259090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
    García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
    Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein.
    Spahn L; Siligan C; Bachmaier R; Schmid JA; Aryee DN; Kovar H
    Oncogene; 2003 Oct; 22(44):6819-29. PubMed ID: 14534527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Ews/Fli-1 fusion gene changes the status of p53 in neuroblastoma tumor cell lines.
    Rorie CJ; Weissman BE
    Cancer Res; 2004 Oct; 64(20):7288-95. PubMed ID: 15492248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mevalonate is essential for growth activation of human fibroblasts: evidence for a critical role of protein glycosylation in the prereplicative period.
    Carlberg M; Hjertman M; Wejde J; Larsson O
    Exp Cell Res; 1994 Jun; 212(2):359-66. PubMed ID: 8187830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.
    Fukuma M; Okita H; Hata J; Umezawa A
    Oncogene; 2003 Jan; 22(1):1-9. PubMed ID: 12527902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ewing's sarcoma fusion protein, EWS/Fli-1 and Fli-1 protein induce PLD2 but not PLD1 gene expression by binding to an ETS domain of 5' promoter.
    Kikuchi R; Murakami M; Sobue S; Iwasaki T; Hagiwara K; Takagi A; Kojima T; Asano H; Suzuki M; Banno Y; Nozawa Y; Murate T
    Oncogene; 2007 Mar; 26(12):1802-10. PubMed ID: 16964281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2and c-Myc expression.
    Dauphinot L; De Oliveira C; Melot T; Sevenet N; Thomas V; Weissman BE; Delattre O
    Oncogene; 2001 May; 20(25):3258-65. PubMed ID: 11423975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EWS/ETS fusions activate telomerase in Ewing's tumors.
    Takahashi A; Higashino F; Aoyagi M; Yoshida K; Itoh M; Kyo S; Ohno T; Taira T; Ariga H; Nakajima K; Hatta M; Kobayashi M; Sano H; Kohgo T; Shindoh M
    Cancer Res; 2003 Dec; 63(23):8338-44. PubMed ID: 14678994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids.
    Athanasiou M; LeGallic L; Watson DK; Blair DG; Mavrothalassitis G
    Cancer Gene Ther; 2000 Aug; 7(8):1188-95. PubMed ID: 10975680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Requirement for mevalonate in the control of proliferation of human breast cancer cells.
    Wejde J; Blegen H; Larsson O
    Anticancer Res; 1992; 12(2):317-24. PubMed ID: 1580550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of the human poly(ADP-ribose) polymerase promoter by the ETS transcription factor.
    Soldatenkov VA; Albor A; Patel BK; Dreszer R; Dritschilo A; Notario V
    Oncogene; 1999 Jul; 18(27):3954-62. PubMed ID: 10435618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of Oct-4 activity by Ewing's sarcoma protein.
    Lee J; Rhee BK; Bae GY; Han YM; Kim J
    Stem Cells; 2005; 23(6):738-51. PubMed ID: 15917470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
    Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
    Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
    Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
    Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new member of the ETS family fused to EWS in Ewing tumors.
    Peter M; Couturier J; Pacquement H; Michon J; Thomas G; Magdelenat H; Delattre O
    Oncogene; 1997 Mar; 14(10):1159-64. PubMed ID: 9121764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.